Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178399 · ClinicalTrials.gov registry record · NA
A Study For Using Radiosurgery On Limited Metastases
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT00178399 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 128 participants.
The verdict
NCT00178399, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The standard therapy in cases such as yours is surgery, radiation therapy, chemotherapy or hormonal therapy alone or in combination. The main purpose of this study is to evaluate whether radiosurgery alone affects your quality and length of life. A second purpose of this study is to determine if the levels of special types of protein (called cytokines) found in the blood are related to your quality of life during your course of treatment and follow-up.
Interventions
- PROCEDURE Stereotactic Body Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2001-04 |
| Est. Completion | 2007-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178399
The ClinicalTrials.gov registry entry for NCT00178399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy is the first listed.
NCT00178399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178399 about?
NCT00178399 is a clinical study titled "A Study For Using Radiosurgery On Limited Metastases". The standard therapy in cases such as yours is surgery, radiation therapy, chemotherapy or hormonal therapy alone or in combination. The main purpose of this study is to evaluate whether radiosurgery alone affects your quality and length of life. A second purpose of this study is to determine if the...
What is the current status of trial NCT00178399?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2001-04. Estimated completion is 2007-03-15.
What interventions are being tested in trial NCT00178399?
The interventions under investigation include: Stereotactic Body Radiation Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00178399?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.